Shilpa Gupta: Kudos to Philippe Spiess and Andrea Necchi on the successes of Global Society of Rare GU Tumors
Shilpa Gupta shared on X:
“The amazing Philippe Spiess kicks off the session on rare GU (genitourinary) cancers in Athens! The definition of ‘rare’ cancers depends on where one lives. Urgent need to tackle the unmet needs globally and get them the funding and attention they deserve.
Parting Greek wisdom pearls from Philippe Spiess, Petros Grivas, Andrea Necchi, Sumanta K. Pal, Neeraj Agarwal, Karima Oualla, Guru P. Sonpavde and Ashish M. Kamat.
Source: Shilpa Gupta/X
Dr. Shilpa Gupta is the Director of Genitourinary Medical Oncology at Taussig Cancer Institute and Co-Leader of the Genitourinary Oncology Program at Cleveland Clinic. Dr. Gupta’s extensive research focuses on novel drug development and biomarkers of response/resistance in bladder cancer, contributing to numerous published works and leadership roles in clinical trials.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023